159 related articles for article (PubMed ID: 21044092)
1. Development of a tier 1 R5 clade C simian-human immunodeficiency virus as a tool to test neutralizing antibody-based immunoprophylaxis.
Siddappa NB; Hemashettar G; Wong YL; Lakhashe S; Rasmussen RA; Watkins JD; Novembre FJ; Villinger F; Else JG; Montefiori DC; Ruprecht RM
J Med Primatol; 2011 Apr; 40(2):120-8. PubMed ID: 21044092
[TBL] [Abstract][Full Text] [Related]
2. R5 clade C SHIV strains with tier 1 or 2 neutralization sensitivity: tools to dissect env evolution and to develop AIDS vaccines in primate models.
Siddappa NB; Watkins JD; Wassermann KJ; Song R; Wang W; Kramer VG; Lakhashe S; Santosuosso M; Poznansky MC; Novembre FJ; Villinger F; Else JG; Montefiori DC; Rasmussen RA; Ruprecht RM
PLoS One; 2010 Jul; 5(7):e11689. PubMed ID: 20657739
[TBL] [Abstract][Full Text] [Related]
3. Induction of neutralizing antibodies against tier 2 human immunodeficiency virus 1 in rhesus macaques infected with tier 1B simian/human immunodeficiency virus.
Himeno A; Ishida Y; Mori H; Matsuura K; Kikukawa M; Sakawaki H; Miura T
Arch Virol; 2019 May; 164(5):1297-1308. PubMed ID: 30820667
[TBL] [Abstract][Full Text] [Related]
4. Standardized assessment of NAb responses elicited in rhesus monkeys immunized with single- or multi-clade HIV-1 envelope immunogens.
Seaman MS; Leblanc DF; Grandpre LE; Bartman MT; Montefiori DC; Letvin NL; Mascola JR
Virology; 2007 Oct; 367(1):175-86. PubMed ID: 17599382
[TBL] [Abstract][Full Text] [Related]
5. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
[TBL] [Abstract][Full Text] [Related]
6. Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies.
Gautam R; Nishimura Y; Lee WR; Donau O; Buckler-White A; Shingai M; Sadjadpour R; Schmidt SD; LaBranche CC; Keele BF; Montefiori D; Mascola JR; Martin MA
J Virol; 2012 Aug; 86(16):8516-26. PubMed ID: 22647691
[TBL] [Abstract][Full Text] [Related]
7. Molecularly cloned SHIV-1157ipd3N4: a highly replication- competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C Env.
Song RJ; Chenine AL; Rasmussen RA; Ruprecht CR; Mirshahidi S; Grisson RD; Xu W; Whitney JB; Goins LM; Ong H; Li PL; Shai-Kobiler E; Wang T; McCann CM; Zhang H; Wood C; Kankasa C; Secor WE; McClure HM; Strobert E; Else JG; Ruprecht RM
J Virol; 2006 Sep; 80(17):8729-38. PubMed ID: 16912320
[TBL] [Abstract][Full Text] [Related]
8. Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection.
Siddappa NB; Song R; Kramer VG; Chenine AL; Velu V; Ong H; Rasmussen RA; Grisson RD; Wood C; Zhang H; Kankasa C; Amara RR; Else JG; Novembre FJ; Montefiori DC; Ruprecht RM
J Virol; 2009 Feb; 83(3):1422-32. PubMed ID: 19019970
[TBL] [Abstract][Full Text] [Related]
9. Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers.
Pauthner MG; Nkolola JP; Havenar-Daughton C; Murrell B; Reiss SM; Bastidas R; Prévost J; Nedellec R; von Bredow B; Abbink P; Cottrell CA; Kulp DW; Tokatlian T; Nogal B; Bianchi M; Li H; Lee JH; Butera ST; Evans DT; Hangartner L; Finzi A; Wilson IA; Wyatt RT; Irvine DJ; Schief WR; Ward AB; Sanders RW; Crotty S; Shaw GM; Barouch DH; Burton DR
Immunity; 2019 Jan; 50(1):241-252.e6. PubMed ID: 30552025
[TBL] [Abstract][Full Text] [Related]
10. Molecularly cloned SHIV-CN97001: a replication-competent, R5 simian/human immunodeficiency virus containing env of a primary Chinese HIV-1 clade C isolate.
Liu Q; Li Y; Yang G; Dai J; Ruprecht RM; Shao Y
J Med Primatol; 2011 Dec; 40(6):427-36. PubMed ID: 21895680
[TBL] [Abstract][Full Text] [Related]
11. Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying
Scinto HB; Gupta S; Thorat S; Mukhtar MM; Griffiths A; Delgado J; Plake E; Vyas HK; Strickland A; Byrareddy SN; Montefiori DC; LaBranche C; Pal R; Treece J; Orndorff S; Ferrari MG; Weiss D; Chenine AL; McLinden R; Michael N; Kim JH; Robb ML; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Ruprecht RM
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743361
[TBL] [Abstract][Full Text] [Related]
12. Immunization with wild-type or CD4-binding-defective HIV-1 Env trimers reduces viremia equivalently following heterologous challenge with simian-human immunodeficiency virus.
Sundling C; O'Dell S; Douagi I; Forsell MN; Mörner A; Loré K; Mascola JR; Wyatt RT; Karlsson Hedestam GB
J Virol; 2010 Sep; 84(18):9086-95. PubMed ID: 20610729
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates.
Saunders KO; Santra S; Parks R; Yates NL; Sutherland LL; Scearce RM; Balachandran H; Bradley T; Goodman D; Eaton A; Stanfield-Oakley SA; Tartaglia J; Phogat S; Pantaleo G; Esteban M; Gomez CE; Perdiguero B; Jacobs B; Kibler K; Korber B; Montefiori DC; Ferrari G; Vandergrift N; Liao HX; Tomaras GD; Haynes BF
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437967
[TBL] [Abstract][Full Text] [Related]
14. Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challenges.
Lakhashe SK; Velu V; Sciaranghella G; Siddappa NB; Dipasquale JM; Hemashettar G; Yoon JK; Rasmussen RA; Yang F; Lee SJ; Montefiori DC; Novembre FJ; Villinger F; Amara RR; Kahn M; Hu SL; Li S; Li Z; Frankel FR; Robert-Guroff M; Johnson WE; Lieberman J; Ruprecht RM
Vaccine; 2011 Aug; 29(34):5611-22. PubMed ID: 21693155
[TBL] [Abstract][Full Text] [Related]
15. The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection.
Charles TP; Burton SL; Arunachalam PS; Cottrell CA; Sewall LM; Bollimpelli VS; Gangadhara S; Dey AK; Ward AB; Shaw GM; Hunter E; Amara RR; Pulendran B; van Gils MJ; Derdeyn CA
PLoS Pathog; 2021 Feb; 17(2):e1009257. PubMed ID: 33556148
[TBL] [Abstract][Full Text] [Related]
16. Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virus.
Lakhashe SK; Byrareddy SN; Zhou M; Bachler BC; Hemashettar G; Hu SL; Villinger F; Else JG; Stock S; Lee SJ; Vargas-Inchaustegui DA; Cofano EB; Robert-Guroff M; Johnson WE; Polonis VR; Forthal DN; Loret EP; Rasmussen RA; Ruprecht RM
Vaccine; 2014 Nov; 32(48):6527-36. PubMed ID: 25245933
[TBL] [Abstract][Full Text] [Related]
17. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC
J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230
[TBL] [Abstract][Full Text] [Related]
18. A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques.
Zhang P; Narayanan E; Liu Q; Tsybovsky Y; Boswell K; Ding S; Hu Z; Follmann D; Lin Y; Miao H; Schmeisser H; Rogers D; Falcone S; Elbashir SM; Presnyak V; Bahl K; Prabhakaran M; Chen X; Sarfo EK; Ambrozak DR; Gautam R; Martin MA; Swerczek J; Herbert R; Weiss D; Misamore J; Ciaramella G; Himansu S; Stewart-Jones G; McDermott A; Koup RA; Mascola JR; Finzi A; Carfi A; Fauci AS; Lusso P
Nat Med; 2021 Dec; 27(12):2234-2245. PubMed ID: 34887575
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel rhesus macaque model with an infectious R5 simian-human immunodeficiency virus encoding HIV-1 CRF08_BC env.
Huang L; Kusagawa S; Zeng H; Yang G; Sun B; Miura T; Yang R
J Med Primatol; 2014 Feb; 43(1):11-21. PubMed ID: 24020838
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T Cells Are Dispensable for Induction of Broad Heterologous HIV Neutralizing Antibodies in Rhesus Macaques.
Sarkar S; Spencer DA; Barnette P; Pandey S; Sutton WF; Basu M; Burch RE; Cleveland JD; Rosenberg AF; Rangel-Moreno J; Keefer MC; Hessell AJ; Haigwood NL; Kobie JJ
Front Immunol; 2021; 12():757811. PubMed ID: 34745131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
